Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1248059.RA9UYrIKbuA9xOGSXRw5yqjjB8-hhU6fBA8gh13EkA7pw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1248059.RA9UYrIKbuA9xOGSXRw5yqjjB8-hhU6fBA8gh13EkA7pw130_assertion type Assertion NP1248059.RA9UYrIKbuA9xOGSXRw5yqjjB8-hhU6fBA8gh13EkA7pw130_head.
- NP1248059.RA9UYrIKbuA9xOGSXRw5yqjjB8-hhU6fBA8gh13EkA7pw130_assertion description "[Daily or every-2-days intravenous treatment of SAR125844 promoted a dose-dependent tumor regression in MET-amplified human gastric cancer models at tolerated doses without treatment-related body weight loss.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248059.RA9UYrIKbuA9xOGSXRw5yqjjB8-hhU6fBA8gh13EkA7pw130_provenance.
- NP1248059.RA9UYrIKbuA9xOGSXRw5yqjjB8-hhU6fBA8gh13EkA7pw130_assertion evidence source_evidence_literature NP1248059.RA9UYrIKbuA9xOGSXRw5yqjjB8-hhU6fBA8gh13EkA7pw130_provenance.
- NP1248059.RA9UYrIKbuA9xOGSXRw5yqjjB8-hhU6fBA8gh13EkA7pw130_assertion SIO_000772 25504634 NP1248059.RA9UYrIKbuA9xOGSXRw5yqjjB8-hhU6fBA8gh13EkA7pw130_provenance.
- NP1248059.RA9UYrIKbuA9xOGSXRw5yqjjB8-hhU6fBA8gh13EkA7pw130_assertion wasDerivedFrom befree-2016 NP1248059.RA9UYrIKbuA9xOGSXRw5yqjjB8-hhU6fBA8gh13EkA7pw130_provenance.
- NP1248059.RA9UYrIKbuA9xOGSXRw5yqjjB8-hhU6fBA8gh13EkA7pw130_assertion wasGeneratedBy ECO_0000203 NP1248059.RA9UYrIKbuA9xOGSXRw5yqjjB8-hhU6fBA8gh13EkA7pw130_provenance.